Outset Medical
78 hedge funds and large institutions have $17.6M invested in Outset Medical in 2024 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 16 increasing their positions, 36 reducing their positions, and 50 closing their positions.
2% more call options, than puts
Call options by funds: $57K | Put options by funds: $56K
36% less funds holding
Funds holding: 122 → 78 (-44)
43.92% less ownership
Funds ownership: 93.94% → 50.02% (-44%)
56% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 36
88% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 50
91% less capital inflows, than outflows
Capital inflows: $5.48M | Capital outflows: $64.5M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GSA Capital Partners
London,
United Kingdom
|
+$1.99M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$959K |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$834K |
| 4 |
Two Sigma Investments
New York
|
+$382K |
| 5 |
Two Sigma Advisers
New York
|
+$268K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$6.72M |
| 2 |
JP Morgan Chase
New York
|
-$6.06M |
| 3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$5.92M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.8M |
| 5 |
Morgan Stanley
New York
|
-$5.22M |
OM Hedge Fund Activity: Q3 2024 in Review
78 of the 6,989 institutional investors tracked by Wall St. Rank reported a position in Outset Medical (OM) for Q3 2024, worth a combined $17.6M — down 91% from $187M a quarter earlier.
Sellers outnumbered buyers: 50 funds closed out of OM and 6 opened new positions — a net loss of 44 holders — while 36 trimmed existing stakes and 16 added.
The largest buyer was GSA Capital Partners, adding an estimated $1.99M. The largest seller was Ameriprise, cutting an estimated $6.72M.
- 78 institutional investors held Outset Medical (OM) as of Q3 2024, down from 122 in Q2 2024.
- Funds reported $17.6M of Outset Medical stock for Q3 2024, down 91% quarter-over-quarter.
- 6 funds opened new Outset Medical positions in Q3 2024 and 50 closed out, a net change of -44 holders.
- The largest Outset Medical buyer in Q3 2024 was GSA Capital Partners, an estimated $1.99M added.
- The largest Outset Medical seller in Q3 2024 was Ameriprise, an estimated $6.72M sold.
Based on aggregated 13F filings for Q3 2024.